← Back to patent-cliff list
CAS 872216-69-8
(Z)-3,4-diphenyl-4-(pyrrolidin-1-yl)but-3-en-2-one
Codes: PARE-012
Application context (from source-drug indications)
Postoperative painParecoxib Sodium神经疾病Parecoxib Sodium肩部疼痛Parecoxib Sodium
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Parecoxib Sodium | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
1,2-diphenylethan-1-one→5-methyl-3,4-diphenyl-4,5-dihydroisoxazol-5-ol→4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide→propionic anhydride→N-((4-(5-methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)propionamide→(Z)-1-(1,2-diphenylvinyl)pyrrolidine→(Z)-3,4-diphenyl-4-(pyrrolidin-1-yl)but-3-en-2-one→5-methyl-3,4-diphenylisoxazole
Intermediates available on this site
Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.
| Supplier | Product | Price band | MOQ | Lead time | Qualifications | Action |
|---|---|---|---|---|---|---|
| Unibest Nantong cGMP Site | 5-Methyl-3,4-diphenylisoxazole Pharmaceutical Intermediates | On request | On request | On request | — |
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.